Try our mobile app
Screener

Reviews

2026-11-17
#reports #XTNT

[Xtant Medical](https://eninvs.com/all.php?name=XTNT) (Medical Devices) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204475)
(2026-05-13, Before Market Open):

- Revenue -27.3% YoY (vs -34.3% in previous quarter and historical rate +14.4%)
- EBITDA -175% YoY (vs -250.0% in previous quarter)
- EBITDA margin -12.5% decreased compared to 12.1% same period last year
- Net Debt increased by $1 mln over the past reporting period (3.5% of market cap)
- FCF (LTM) -$0 bln (negative), 45.2% of market cap
- EV/Sales multiple is 0.4x

2026-11-17
#reports #WKHS

[Workhorse Group](https://eninvs.com/all.php?name=WKHS) (Electric vehicles and aircraft manufacturer) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204472)
(2026-05-14, After Market Close):

- Revenue +500% YoY (vs +300.0% in previous quarter and historical rate +68.7%)
- EBITDA margin -283.3% increased compared to -15300.0% same period last year
- Net Debt increased by $14 mln over the past reporting period (45.6% of market cap)
- FCF (LTM) -$0.1 bln (negative), 299.6% of market cap
- EV/Sales multiple is 7.4x

2026-11-17
#reports #VERI

[Veritone](https://eninvs.com/all.php?name=VERI) (Software — Infrastructure) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204483)
(2026-05-12, Before Market Open):

- Revenue -20.8% YoY (vs +9.1% in previous quarter and historical rate -10.5%)
- EBITDA margin -42.1% increased compared to -50.0% same period last year
- Net Debt increased by $5 mln over the past reporting period (13.4% of market cap)
- FCF (LTM) +$0 bln (positive), 53.5% of market cap
- EV/Sales multiple is 0.8x

2026-11-17
#reports #STXS

[Stereotaxis](https://eninvs.com/all.php?name=STXS) (Medical Instruments and Supplies) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204465)
(2026-05-12, After Market Close):

- Revenue 0% YoY (vs +60.0% in previous quarter and historical rate +7.7%)
- EBITDA margin -66.7% has not changed compared to -66.7% same period last year
- Net Debt increased by $9 mln over the past reporting period (10.7% of market cap)
- FCF (LTM) -$0 bln (negative), 3.6% of market cap
- EV/Sales multiple is 2.9x

2026-11-17
#reports #SMID

[Smith-Midland Corporation](https://eninvs.com/all.php?name=SMID) (Building Materials) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204534)
(2025-11-14, After Market Close):

- Revenue -4.2% YoY (vs +15.0% in previous quarter and historical rate +27.6%)
- EBITDA +40% YoY (vs 0.0% in previous quarter and historical rate +65.0%)
- EBITDA margin 30.4% increased compared to 20.8% same period last year
- Net Debt increased by $2 mln over the past reporting period (1.9% of market cap)
- FCF (LTM) -$0 bln (negative), 2.8% of market cap
- EV/EBITDA multiple is 6.1x compared to historical level (75th percentile) of 24.1x
- EV/Sales multiple is 1.1x

At the opening of the session the share price went down -1.8%
2026-11-17
#reports #RPID

[Rapid Micro Biosystems, Inc.](https://eninvs.com/all.php?name=RPID) (Medical Devices) reported for 2026 q3
(2026-05-13, After Market Close):

- Revenue +25% YoY (vs +14.3% in previous quarter and historical rate +21.2%)
- EBITDA margin -100.0% increased compared to -137.5% same period last year
- Net Debt increased by $13 mln over the past reporting period (35.9% of market cap)
- FCF (LTM) -$0 bln (negative), 58.1% of market cap
- EV/Sales multiple is 1.4x

2026-11-17
#reports #RDIB

[Reading International](https://eninvs.com/all.php?name=RDIB) (Entertainment) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204527)
(2026-05-15, Before Market Open):

- Revenue +44.4% YoY (vs 0.0% in previous quarter and historical rate +15.0%)
- EBITDA +350% YoY (vs -100.0% in previous quarter)
- EBITDA margin 13.8% increased compared to 4.4% same period last year
- Net Debt decreased by $10 mln over the past reporting period (3.6% of market cap)
- FCF (LTM) -$0 bln (negative), 5.7% of market cap
- EV/EBITDA multiple is 156.6x compared to historical level (75th percentile) of 217x
- EV/Sales multiple is 2.9x

2026-11-17
#reports #QLGN

[Qualigen Therapeutics](https://eninvs.com/all.php?name=QLGN) (Biotechnology) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204476)
(2025-11-14):

- Revenue +100% YoY (vs +400.0% in previous quarter and historical rate +65.3%)
- EBITDA margin -107625.0% decreased compared to -200.0% same period last year
- Net Debt increased by $4 bln since the start of the year (319254.3% of market cap)
- FCF (LTM) -$0 bln (negative), 161.0% of market cap
- EV/Sales multiple is 208.9x

2026-11-17
#reports #PPSI

[Pioneer Power Solutions](https://eninvs.com/all.php?name=PPSI) (Electrical Equipment and Parts) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204474)
(2026-05-18, Before Market Open):

- Revenue -54.5% YoY (vs -16.7% in previous quarter and historical rate +15.5%)
- EBITDA margin -60.0% decreased compared to -9.1% same period last year
- Net Debt increased by $1 mln over the past reporting period (4.1% of market cap)
- FCF (LTM) +$0 bln (positive), 53.7% of market cap
- EV/Sales multiple is 0.8x

2026-11-17
#reports #PBHC

[Pathfinder Bancorp](https://eninvs.com/all.php?name=PBHC) (Banks — Regional) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204482)
(2025-05-01, After Market Close):

- Revenue -45% YoY (vs -45.0% in previous quarter and historical rate -0.2%)
- Net Income -100% YoY (vs -100.0% in previous quarter and historical rate +8.3%)
- P/E multiple is 36x compared to historical level (75th percentile) of 70x
- P/S multiple is 3x
- Price to book: 0.9x

At the opening of the session the share price went up +1.3%
2026-11-17
#reports #NFE

[New Fortress Energy](https://eninvs.com/all.php?name=NFE) (Electricity supplier) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204495)
(2026-05-29, Before Market Open):

- Revenue -85.8% YoY (vs -42.4% in previous quarter and historical rate +3.0%)
- EBITDA -238.1% YoY (vs -105.8% in previous quarter and historical rate -47.3%)
- EBITDA margin -130.7% decreased compared to 13.4% same period last year
- Net Debt decreased by $4.9 bln since the start of the year (780.3% of market cap)
- FCF (LTM) -$0.2 bln (negative), 25.3% of market cap
- EV/Sales multiple is 3.5x

2026-11-17
#reports #MSN

[Emerson Radio](https://eninvs.com/all.php?name=MSN) (Consumer Electronics) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204523)
(2026-06-26, After Market Close):

- Revenue 0% YoY (vs -33.3% in previous quarter and historical rate +17.4%)
- EBITDA margin -50.0% has not changed compared to -50.0% same period last year
- Net Debt increased by $3 mln over the past reporting period (50.0% of market cap)
- FCF (LTM) -$0 bln (negative), 333.1% of market cap
- EV/EBITDA multiple is 0.2x compared to historical level (75th percentile) of 1.4x
- EV/Sales multiple is -0.1x

2026-11-17
#reports #MNTK

[Montauk Renewables, Inc.](https://eninvs.com/all.php?name=MNTK) (Utilities — Diversified) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204506)
(2026-05-07, After Market Close):

- Revenue +25% YoY (vs +31.7% in previous quarter and historical rate +7.2%)
- EBITDA -73.1% YoY (vs -63.6% in previous quarter and historical rate +58.6%)
- EBITDA margin 14.0% decreased compared to 65.0% same period last year
- Net Debt increased by $3 mln over the past reporting period (1.8% of market cap)
- FCF (LTM) -$0.1 bln (negative), 44.8% of market cap
- EV/EBITDA multiple is 3.9x compared to historical level (75th percentile) of 7.9x
- EV/Sales multiple is 1.8x

2026-11-17
#reports #MLP

[Maui Land & Pineapple Company](https://eninvs.com/all.php?name=MLP) (Real Estate Services) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204526)
(2026-04-01, After Market Close):

- Revenue +33.3% YoY (vs +33.3% in previous quarter and historical rate +15.8%)
- EBITDA margin -25.0% increased compared to -66.7% same period last year
- Net Debt increased by $3 mln over the past reporting period (1.0% of market cap)
- FCF (LTM) +$0 bln (positive), 9.6% of market cap
- EV/Sales multiple is 18.9x

2026-11-17
#reports #IPDN

[Professional Diversity Network](https://eninvs.com/all.php?name=IPDN) (Staffing and Employment Services) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204480)
(2026-03-31):

- Revenue -49.5% YoY (vs +58950.0% in previous quarter and historical rate +70.9%)
- EBITDA margin -309.0% decreased compared to -25.0% same period last year
- Net Debt decreased by $560 mln over the past reporting period (150013.5% of market cap)
- FCF (LTM) +$2.6 bln (positive), 690062.2% of market cap
- EV/EBITDA multiple is 0.3x compared to historical level (75th percentile) of 0.2x
- EV/Sales multiple is -0.3x

2026-11-17
#reports #IDXG

[Interpace Biosciences](https://eninvs.com/all.php?name=IDXG) (Diagnostics and Research) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204458)
(2026-05-12, After Market Close):

- Revenue -16.7% YoY (vs -25.0% in previous quarter and historical rate +18.6%)
- EBITDA -200% YoY (vs -66.7% in previous quarter)
- EBITDA margin -20.0% decreased compared to 16.7% same period last year
- Net Debt decreased by $1 mln over the past reporting period (2.7% of market cap)
- FCF (LTM) +$0 bln (positive), 13.7% of market cap
- EV/EBITDA multiple is 8.4x compared to historical level (75th percentile) of 10.7x
- EV/Sales multiple is 0.5x

2026-11-17
#reports #HYFM

[Hydrofarm Holdings Group, Inc.](https://eninvs.com/all.php?name=HYFM) (Farm and Heavy Construction Machinery) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204493)
(2026-03-27):

- Revenue -51.7% YoY (vs -41.0% in previous quarter and historical rate -27.5%)
- EBITDA margin 50.0% increased compared to -6.9% same period last year
- Net Debt decreased by $7 mln over the past reporting period (22.2% of market cap)
- FCF (LTM) -$0 bln (negative), 3.2% of market cap
- EV/Sales multiple is 1.9x

2026-11-17
#reports #ENTA

[Enanta Pharmaceuticals](https://eninvs.com/all.php?name=ENTA) (Small molecular drugs manufacturer) reported for 2026 q3
(2026-05-11, After Market Close):

- Revenue -13.3% YoY (vs -22.2% in previous quarter and historical rate -3.7%)
- EBITDA margin -438.5% decreased compared to -353.3% same period last year
- Net Debt decreased by $138 mln over the past reporting period (44.4% of market cap)
- FCF (LTM) +$0 bln (positive), 11.9% of market cap
- EV/Sales multiple is 2.7x

2026-11-17
#reports #EC

[Ecopetrol](https://eninvs.com/all.php?name=EC) (Oil and Gas Integrated) reported for 2026 q3
(2026-05-12, After Market Close):

- Revenue +44.8% YoY (vs +56.8% in previous quarter and historical rate +3.8%)
- EBITDA +60.8% YoY (vs +49.1% in previous quarter and historical rate +3.7%)
- EBITDA margin 42.5% increased compared to 38.2% same period last year
- Net Debt increased by $5.8 bln since the start of the year (17.8% of market cap)
- FCF (LTM) +$2.1 bln (positive), 6.3% of market cap
- EV/EBITDA multiple is 4.8x compared to historical level (75th percentile) of 5.5x
- EV/Sales multiple is 1.7x

2026-11-17
#reports #BBGI

[Beasley Broadcast Group](https://eninvs.com/all.php?name=BBGI) (Broadcasting) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204462)
(2026-04-08, Before Market Open):

- Revenue -19.3% YoY (vs -9.8% in previous quarter and historical rate -10.6%)
- EBITDA -350.7% YoY (vs +483900.0% in previous quarter and historical rate +23.7%)
- EBITDA margin -26.3% decreased compared to 8.5% same period last year
- Net Debt decreased by $11.9 bln since the start of the year (129665.7% of market cap)
- FCF (LTM) +$78.8 bln (positive), 861865.4% of market cap
- EV/EBITDA multiple is 76.5x compared to historical level (75th percentile) of 18x
- EV/Sales multiple is 0.9x

2026-11-17
#reports #AYTU

[Aytu Biopharma](https://eninvs.com/all.php?name=AYTU) (Drug Manufacturers — Specialty and Generic) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204468)
(2026-05-13, After Market Close):

- Revenue +7.1% YoY (vs +6.7% in previous quarter and historical rate -15.7%)
- EBITDA -200% YoY (vs 0.0% in previous quarter)
- EBITDA margin -20.0% decreased compared to 21.4% same period last year
- EV/Sales multiple is 0.5x